Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Use of proton pump inhibitors and risk of osteoporosis-related fractures.

Targownik LE, Lix LM, Metge CJ, Prior HJ, Leung S, Leslie WD.

CMAJ. 2008 Aug 12;179(4):319-26. doi: 10.1503/cmaj.071330.

2.

Proton pump inhibitors and bone fractures?

Laine L.

Am J Gastroenterol. 2009 Mar;104 Suppl 2:S21-6. doi: 10.1038/ajg.2009.48. Review.

PMID:
19262543
3.

Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies.

Ngamruengphong S, Leontiadis GI, Radhi S, Dentino A, Nugent K.

Am J Gastroenterol. 2011 Jul;106(7):1209-18; quiz 1219. doi: 10.1038/ajg.2011.113. Epub 2011 Apr 12. Review.

PMID:
21483462
4.

Proton pump inhibitors, osteoporosis, and osteoporosis-related fractures.

Fournier MR, Targownik LE, Leslie WD.

Maturitas. 2009 Sep 20;64(1):9-13. doi: 10.1016/j.maturitas.2009.07.006. Epub 2009 Aug 11. Review.

PMID:
19674854
5.

Proton pump inhibitors therapy and risk of hip fracture: a systematic review and meta-analysis.

Ye X, Liu H, Wu C, Qin Y, Zang J, Gao Q, Zhang X, He J.

Eur J Gastroenterol Hepatol. 2011 Sep;23(9):794-800. doi: 10.1097/MEG.0b013e328348a56a. Review.

PMID:
21701389
6.

Fracture risk and bone mineral density reduction associated with proton pump inhibitors.

Lau YT, Ahmed NN.

Pharmacotherapy. 2012 Jan;32(1):67-79. doi: 10.1002/PHAR.1007. Review.

PMID:
22392829
7.

Epidemiology of osteoporotic fractures.

Johnell O, Kanis J.

Osteoporos Int. 2005 Mar;16 Suppl 2:S3-7. Epub 2004 Sep 8. Review.

PMID:
15365697
8.

Proton pump-inhibiting drugs, calcium homeostasis, and bone health.

Wright MJ, Proctor DD, Insogna KL, Kerstetter JE.

Nutr Rev. 2008 Feb;66(2):103-8. doi: 10.1111/j.1753-4887.2008.00015.x. Review.

PMID:
18254877
9.

[Drug-induced osteoporosis].

Briot K.

Rev Prat. 2012 Feb;62(2):187-92. Review. French.

PMID:
22408857
10.

The relationship among proton pump inhibitors, bone disease and fracture.

Targownik LE, Leslie WD.

Expert Opin Drug Saf. 2011 Nov;10(6):901-12. doi: 10.1517/14740338.2011.586628. Epub 2011 May 20. Review.

PMID:
21599546
11.

[Long-term proton pump inhibitor therapy and osteoporosis. Is there a real danger?].

Maléth J, Hegyi P.

Orv Hetil. 2013 Jun 30;154(26):1005-9. doi: 10.1556/OH.2013.29656. Review. Hungarian.

PMID:
23800385
12.

[Pharmacogenic osteoporosis beyond cortisone. Proton pump inhibitors, glitazones and diuretics].

Kann PH, Hadji P, Bergmann RS.

Z Rheumatol. 2014 May;73(4):323-8. doi: 10.1007/s00393-013-1286-7. Review. German.

PMID:
24728601
13.

[Secondary osteoporosis or secondary contributors to bone loss in fracture. Metabolic bone disease and fracture induced by drugs].

Suzuki H.

Clin Calcium. 2013 Sep;23(9):1307-12. doi: CliCa130913071312. Review. Japanese.

PMID:
23999367
14.

Proton pump inhibitor therapy and osteoporosis.

Yang YX.

Curr Drug Saf. 2008 Sep;3(3):204-9. Review.

PMID:
18691003
15.

[Atypical subtrochanteric fractures after long-term bisphosphonate therapy].

Czerwiński E.

Endokrynol Pol. 2011;62 Suppl 2:42-5. Review. Polish.

PMID:
22125022
16.

Risk factors for the second contralateral hip fracture in elderly patients: a systematic review and meta-analysis.

Liu S, Zhu Y, Chen W, Sun T, Cheng J, Zhang Y.

Clin Rehabil. 2015 Mar;29(3):285-94. doi: 10.1177/0269215514542358. Epub 2014 Jul 15. Review.

PMID:
25027445
17.

The relationship between long-term proton pump inhibitor therapy and skeletal frailty.

Lau AN, Tomizza M, Wong-Pack M, Papaioannou A, Adachi JD.

Endocrine. 2015 Aug;49(3):606-10. doi: 10.1007/s12020-015-0576-z. Epub 2015 May 7. Review.

18.

Proton pump inhibitors and fracture risk: true effect or residual confounding?

Bodmer M, Meier C, Kraenzlin ME, Meier CR.

Drug Saf. 2010 Oct 1;33(10):843-52. doi: 10.2165/11536780-000000000-00000. Review.

PMID:
20812769
19.

[Proton pump inhibitors and their effect on the bone].

Ječmenová M, Kroupa R.

Vnitr Lek. 2016 Feb;62(2):139-46. Review. Czech.

PMID:
27172441
20.

[Emergent adverse effects of proton pump inhibitors].

Bourne C, Charpiat B, Charhon N, Bertin C, Gouraud A, Mouchoux C, Skalli S, Janoly-Dumenil A.

Presse Med. 2013 Feb;42(2):e53-62. doi: 10.1016/j.lpm.2012.09.016. Epub 2012 Dec 10. Review. French.

PMID:
23237784

Supplemental Content

Support Center